Showing results (161-170 of 4,808) with videos related to
Sort By:
Pageof 481
Physical Review Letters|November 12, 2013
Simulating all nonsignaling correlations via classical or quantum theory with negative probabilitiesSabri W Al-Safi, Anthony J ShortChest|December 1, 1990
Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shockR L Danner, C Natanson, R J Elin, et al.The American Journal of Medicine|March 1, 1988
Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndromeP L Rogers, R E Walker, H C Lane, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patientsR F Ozols, R E Cunnion, R W Klecker, et al.The American Journal of Tropical Medicine and Hygiene|November 1, 1988
Efficacy of trimetrexate, a potent lipid-soluble antifolate, in the treatment of rodent Pneumocystis carinii pneumoniaJ A Kovacs, C J Allegra, S Kennedy, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|May 1, 1991
Factors that determine the hemodynamic response to inhalation anestheticsW D Hoffman, S M Banks, D W Alling, et al.The New England Journal of Medicine|August 3, 1989
The cardiovascular response of normal humans to the administration of endotoxinA F Suffredini, R E Fromm, M M Parker, et al.Journal of the American College of Cardiology|October 8, 1997
Does low individual operator coronary interventional procedural volume correlate with worse institutional procedural outcome?L W Klein, G L Schaer, J E Calvin, et al.Journal of the American College of Cardiology|December 31, 1997
Echocardiography for hemodynamic assessment of patients with advanced heart failure and potential heart transplant recipientsJ H Stein, A Neumann, L M Preston, et al.Antimicrobial Agents and Chemotherapy|April 1, 1988
Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolateJ A Kovacs, C J Allegra, J C Swan, et al.Pageof 481